Calf's lung surfactant extract in acute hypoxemic respiratory failure in children

Critical Care Medicine

Volumn 24, Issue 8, 1996, Pages 1316-1322

  Willson, Douglas F ^a   Jiao, Jin Hua ^a   Bauman, Loren A ^b   Zaritsky, Arno ^c   Craft, Hugh ^d   Dockery, Keith ^e   Conrad, Debra ^f   Dalton, Heidi ^g  

^a UNIVERSITY OF VIRGINIA   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c CHILDREN S HOSPITAL OF THE KING S DAUGHTERS   (United States)

^d JEFFERSON COLLEGE OF HEALTH SCIENCES   (United States)

^e INOVA FAIRFAX HOSPITAL   (United States)

^f Henrico Doctor's Hospital   (United States)

^g GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

acute respiratory failure; adult respiratory distress syndrome; barotrauma; hypoxemia; mechanical ventilation; oxygenation index; pneumonia; surfactant

Indexed keywords

LUNG SURFACTANT EXTRACT;

ACUTE RESPIRATORY FAILURE; ADOLESCENT; ARTERIAL GAS; ARTICLE; ARTIFICIAL VENTILATION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; FEMALE; HUMAN; INTENSIVE CARE; INTRATRACHEAL DRUG ADMINISTRATION; LUNG INFILTRATE; LUNG VENTILATION; MALE; MORTALITY; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0029809082     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199608000-00008     Document Type: Article

References (31)

1. DeBruin W, Notterman DA, Magid M, et al: Acute hypoxemic respiratory failure in infants and children: Clinical and pathologic characteristics. Crit Care Med 1992; 20:1223-1234
2. Petersen GW, Baier H: Incidence of pulmonary barotrauma in a medical ICU. Crit Care Med 1983; 11:67-69
3. Woodring JH: Pulmonary interstitial emphysema in the adult respiratory distress syndrome. Crit Care Med 1985; 13:786-791
4. Haake R, Schlichtig R, Ulstad DR, et al: Barotrauma pathophysiology, risk factors, and prevention. Chest 1987; 91: 608-613
5. Tsuno K, Prato P, Kolobow T: Acute lung injury from mechanical ventilation at moderately high airway pressures. J Appl Physiol 1990; 69:956-961
6. Hamilton PP, Onayemi A, Smith JA, et al: Comparison of conventional and high frequency ventilation: Oxygenation and lung pathology. J Appl Physiol 1983; 55:131-138
7. 2 removal with conventional mechanical ventilation in experimental hyaline membrane disease. Intensive Care Med 1989; 15:184-191
8. Kolobow T, Moretti MP, Fumagalli R, et al: Severe impairment in lung function induced by high peak airway pressure during mechanical ventilation. An experimental study. Am Rev Respir Dis 1987; 135:312-315
9. Lamm WJE, Albert RK: Surfactant replacement improves lung recoil in rabbit lungs after acid aspiration. Am Rev Respir Dis 1990; 142:1279-1283
10. van Daal G, So KL, Gommers D, et al: Intratracheal surfactant administration restores gas exchange in experimental adult respiratory distress syndrome associated with viral pneumonia. Anesth Analg 1991; 72:589-595
11. Holm BA, Notter RH, Seigle J, et al: Pulmonary physiological and surfactant changes during injury and recovery from hyperoxia. J Appl Physiol 1985; 59: 1402-1409
12. Horbar JD, Soll RF, Sutherland JM, et al: A multicenter, randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome. N Engl J Med 1989; 320:959-965
13. Kendig JW, Notter RH, Cox C, et al: Surfactant replacement therapy at birth: Final analysis of a clinical trial and comparisons with similar trials. Pediatrics 1988; 82:756-762
14. Collaborative European Multicenter Study Group: Surfactant replacement for severe neonatal respiratory distress syndrome: An international randomized clinical trial. Pediatrics 1988; 82: 683-691
15. Merritt TA, Hallman M, Bloom BT, et al: Prophylactic treatment of very premature infants with human surfactant. N Engl J Med 1986; 315:785-790
16. Gitlin JD, Soll RF, Parad RB, et al: Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease. Pediatrics 1987; 79: 31-37
17. Jobe A, Ikegami M, Glatz T, et al: Duration and characteristics of treatment of premature lambs with natural surfactant. J Clin Invest 1981; 67:370-375
18. Bohn D, Tamura M, Perrin D, et al: Ventilatory predictors of pulmonary hypoplasia in congenital diaphragmatic hernia, confirmed by morphological assessment. J Pediatr 1987; 111:423-431
19. Hallman M, Merritt TA, Pohjavuori M, et al: Effect of surfactant substitution on lung effluent phospholipids in respiratory distress syndrome: Evaluation of surfactant phospholipid turnover, pool size, and the relationship to severity of respiratory failure. Pediatr Res 1986; 20:1228-1235
20. Merritt TA, Hallman M, Spragg R, et al: Exogenous surfactant treatments for neonatal respiratory distress syndrome and their potential role in the adult respiratory distress syndrome. Drugs 1989; 38:591-611
21. Timmons OD, Havens PL, Fackler JC: Predicting death in pediatric patients with acute respiratory failure. Chest 1995; 108:789-797
22. Weg JG, Balk RA, Tharratt S, et al: Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome. JAMA 1994; 272:1433-1438
23. Gregory TJ, Longmore WJ, Moxley MA, et al: Surfactant repletion following Survanta supplementation in patients with acute respiratory distress syndrome (ARDS). Abstr. Respiratory and Critical Care Medicine 1994; 149:A124
24. Lewis J, Dhillon J, Frewen T: Exogenous surfactant therapy in pediatric patients with ARDS. Abstr. Respiratory and Critical Care Medicine 1994; 149:A125
25. Cummings JJ, Holm BA, Hudak ML, et al: A controlled clinical comparison of four different surfactant preparations in surfactant-deficient preterm lambs. Am Rev Respir Dis 1992; 145:999-1004
26. Bloom BT, Delmore P, Kattwinkle J, et al: Randomized double blind multicenter trial of Survanta and Infasurf. Abstr. Pediatr Res 1994;35:326A
27. Hudak M, Matteson E, Baus J, et al: Infasurf V. Exosurf for the prophylaxis of RDS: A ten center randomized double-masked comparison trial. Abstr. Pediatr Res 1994;35:231A
28. Hudak M, Matteson E, Baus J, et al: Infasurf V. Exosurf for the treatment of RDS: A 21 center randomized double-masked comparison trial. Abstr. Pediatr Res 1994; 35:231A
29. Lewis JF, McCaig L, Goffin J, et al: Surfactant delivery technique influences the efficacy of exogenous surfactant preparations in acute lung injury. Abstr. Respiratory and Critical Care Medicine 1994; 149:A125
30. MacIntyre NR, Coleman RE, Schuller FS, et al: Efficiency of the delivery of aerosolized artificial surfactant to intubated patients with the adult respiratory distress syndrome. Abstr. Respiratory and Critical Care Medicine 1994; 149:A125
31. Kattwinkle J, Bloom BT, Delmore P, et al: Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks' gestation. Pediatrics 1993; 92:90-98